Testosterone FDA Warnings: What Changed and What Remains

Checking a testosterone warning? FDA changed heart-risk wording in 2025 and asked for more label changes in June 2026. Ask about blood pressure and the exact product guide.

Who may have a warning-related claim to check?

Ask about the exact product, harm and law if you want a claim check. A drug warning alone does not prove cause. Keep the guide and its date.

FDA’s February 2025 action removed increased cardiovascular-risk boxed wording while adding blood-pressure warnings. That is different from saying all testosterone warnings disappeared. Keep the medicine’s actual guide and discuss what applies to your health rather than relying on an old headline.

What does not qualify as proof of zero risk?

The trial does not prove zero risk for each user. It tested a set group for a set time. Other safety differences still matter.

TRAVERSE used a skin gel in men with low-testosterone symptoms and existing or high cardiovascular risk. The main outcome met its noninferiority margin, meaning the trial did not exceed the set risk margin against placebo. More lung clots, irregular heart rhythm and kidney injury occurred in the treated group.

What if my label still has older age or prostate wording?

Ask the pharmacist for your product’s current guide. FDA asked for more changes in June 2026. That does not show every guide has changed.

HHS distinguishes requested age-related and prostate changes from completed updates to every label. It also notes long-term prostate uncertainties and continued monitoring. The selected July 2025 gel label predates that request, so it should not be presented as the last word on all those issues.

Which warning and care records should I keep?

Keep the product, guide, prescription dates and clinical records. Add any warning letter you received. Ask the clinician to explain changes that affect your care.

The dated AndroGel label retains a boxed warning about unintended testosterone transfer to children. It also addresses blood pressure and clot concerns. Those are different safety questions from the trial’s main cardiac composite; retain the actual documents without treating a warning as proof of personal cause.

Does a label change create a filing deadline?

Ask a lawyer which claim and law set your time limit. A drug notice is not a personal filing date. No national cutoff is supplied here.

The court’s general explanation says limitation periods depend on the claim and law. Keep the dates of use, injury and any prior legal action for that review. Do not delay urgent care while searching for a label date or assume a regulation itself filed your case.

What happens when I check a warning-related claim?

Ask which drug and harm the lawyer will check. Read the fee and expense terms. Seek medical care for urgent signs while that review is pending.

Read how recovery-based fees and expenses are handled, including costs after a loss. FDA’s actions and the trial supply evidence to interpret, not a guarantee of firm acceptance or compensation. Ask for a clear explanation of what record or next legal step is needed.